Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Isoproterenol and Quinidine

supplement:

Quinidine

Research Papers that Mention the Interaction

However, the amount of decrease in QRS duration and VTCL with isoproterenol was greater during procainamide and quinidine than in the drug-free state (ANOVA interaction, p<0.02 for all).
Isoproterenol shortened the sinus cycle length, QT interval during ventricular pacing, and ventricular effective and functional refractory periods before and during procainamide and quinidine therapy (ANOVA; isoproterenol effect, p.0.0002 for all).
Circulation  •  1993  |  View Paper
The following results were obtained: (1) quinidine had a depressant effect on myocardial contractile force; (2) quinidine reduced the maximal upstroke velocity of … prolonged the terminal repolarization of the action potential; (4) at higher concentrations quinidine reduced the resting potential; and (5) the depression by quinidine of … by isoprenaline.
Journal of cardiovascular pharmacology  •  1979  |  View Paper
Abstract A prolongation of conduction time induced by sublethal doses of quinidine (as shown by a broadening of the QRS interval), as well as a decrease in myocardial contractility are prevented by simultaneous administration of isoproterenol.
When isoproterenol is in combination with fatal doses of quinidine , it reduces lethality from 100 to 25 per cent; the dose of isoproterenol required is, however, a critical one, since high doses even increase quinidine toxicity.
American heart journal  •  1963  |  View Paper
Quinidine , a class I antiarrhythmic agent has been found to exhibit a protective role in isoproterenol induced myocardial ischaemia.
Molecular and Cellular Biochemistry  •  2004  |  View Paper
Quinidine (class I), verapamil (IV), diltiazem (IV), dilazep (IV), nifedipine (IV), tetrodotoxin and butoxamine, at a concentration of 10 μmol/l, significantly decreased the extraneuronal accumulation of isoprenaline.
The antiarrhythmic effects of quinidine and calcium channel blockers in this experimental model may be partly due to a decrease in the extraneuronal accumulation of isoprenaline.
The present study demonstrated that quinidine (class I) and all of the calcium channel blockers (class IV) had potent inhibitory effects on the extraneuronal accumulation of isoprenaline.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
The effects of quinidine on slow inward current and force of contraction in ventricular muscle were antagonized by isoprenaline (1 micrometer).
The Journal of pharmacology and experimental therapeutics  •  1981  |  View Paper
Procaine and quinidine inhibit Ca 2+ accumulation by fraction and suppress the relaxation of this tissue induced by papaverine, isoprenaline and phenylephrine.
Biochemical pharmacology  •  1975  |  View Paper
All the drugs are antiarrhythmic agents with local anesthetic activity, but propranolol and quinidine are known also to have beta-receptor-blocking actions in that they can prevent the cardiac effects of isoprenaline and depress the myocardium.
Circulation research  •  1969  |  View Paper
In the presence of 25 µg/liter of isoproterenol , 8 mg/liter of quinidine decreased the ERP 27% from the controls (P < .05).
The Journal of pharmacology and experimental therapeutics  •  1969  |  View Paper